5 febrero 2015
BGI has published a study tracking the clinical performance of its whole genome sequencing-based non-invasive prenatal test (the NIFTY test) in nearly 147,000 pregnancies, the largest such study to date. The results showed high sensitivity and specificity and no significant difference between high-risk and low-risk pregnant women.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/j9_Wa2UEP6A/150205102125.htm
